NCT02507713 Quantitative Neuromuscular Ultrasonography in Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase N/A
NCT02496767 Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year Status COMPLETED Phase PHASE3
NCT02492516 Intravenous Injection of Adipose Derived Mesenchymal Stem Cell for ALS Status COMPLETED Phase PHASE1
NCT02487407 Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT02479802 Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE2
NCT02478450 Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS) Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT02460679 Safety and Biomarker Study of EPI-589 in Participants With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE2
NCT02447952 Exploratory Study of Biotelemetry in Amyotrophic Lateral Sclerosis Status COMPLETED Phase NA
NCT02437110 HERV-K Suppression Using Antiretroviral Therapy in Volunteers With Amyotrophic Lateral Sclerosis (ALS) Status COMPLETED Phase PHASE1
NCT02418546 Electronic-health Application To Measure Outcomes REmotely Clinical Trial Status COMPLETED Phase NA
NCT02383654 Compassionate Treatment : An Exploratory Clinical Trial to Assess Treatment of Amyotrophic Lateral Sclerosis Status COMPLETED Phase PHASE1
NCT02360891 Study of Predictive Factors of Progression of Motor Neurone Disease Status COMPLETED Phase N/A
NCT02327845 Phenotype, Genotype & Biomarkers in ALS and Related Disorders Status ENROLLING_BY_INVITATION Phase N/A